Edwards Lifesciences Corp. Stock
We can see a decrease in the price for Edwards Lifesciences Corp.. Compared to yesterday it has lost -€1.100 (-1.630%).
With 31 Buy predictions and not a single Sell prediction Edwards Lifesciences Corp. is an absolute favorite of our community.
As a result the target price of 80 € shows a positive potential of 20.48% compared to the current price of 66.4 € for Edwards Lifesciences Corp..
For the coming years our community has positive and negative things to say abot the Edwards Lifesciences Corp. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Edwards Lifesciences Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Edwards Lifesciences Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Edwards Lifesciences Corp. | -1.630% | -5.480% | -10.161% | 8.995% | -10.258% | -13.564% | -8.084% |
| Veeva Systems A | -4.210% | -14.418% | -21.136% | -31.385% | -32.585% | -21.663% | -41.847% |
| Thermo Fisher Scientific Inc. | -0.910% | -0.657% | -1.844% | 11.152% | -14.387% | -19.685% | 5.144% |
| Intuitive Surgical Inc | -1.140% | -1.990% | -8.162% | -12.051% | -21.445% | 63.337% | 74.871% |
Comments
Edwards Lifesciences (EW) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $92.00 price target on the stock.
Show more
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) had its price target raised by analysts at Wells Fargo & Company from $96.00 to $100.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for EW provided by MarketBeat
Edwards Lifesciences (NYSE:EW) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Show more
Ratings data for EW provided by MarketBeat